Status:
COMPLETED
Wound Infiltration and Breast Cancer Surgery
Lead Sponsor:
Tenon Hospital, Paris
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Prospective double blind randomized evaluation of the effect of surgical wound infiltration with ropivacaine versus placebo in patients scheduled for breast surgery with axillary lymph node dissection
Detailed Description
This is a prospective, double-blind, randomized, single centre study Adult ASA I - II patients, scheduled for unilateral mastectomy or tumorectomy associated with axillary lymph node dissection are in...
Eligibility Criteria
Inclusion
- Adult ASA I - II patients, scheduled for unilateral mastectomy or tumorectomy associated with axillary lymph node dissection
Exclusion
- Patients receiving opioid or any other analgesic treatment for chronic pain before surgery, patients with known allergy to local anaesthetics, and patients with acquired or genetic haemostatic abnormality
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01404377
Start Date
January 1 2006
End Date
January 1 2009
Last Update
July 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Tenon
Paris, France, 75020